DIETSAN: Different Bowel Preparations in CT Colonography: is Diet Necessary? A Randomized Controlled Trial

Sponsor
University of Roma La Sapienza (Other)
Overall Status
Completed
CT.gov ID
NCT02371655
Collaborator
(none)
100
1
2
14
7.1

Study Details

Study Description

Brief Summary

The aim of this study is to compare a new regimen of reduced bowel preparation that does not include low fiber diet with another reduced bowel preparation including low-fiber diet.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Diet
  • Drug: Faecal Tagging
  • Drug: Bowel cleansing
  • Procedure: CT colonography
N/A

Detailed Description

Bowel preparation should be safe and well tolerated by patients, particularly in a screening setting. For this reason, limited bowel preparations have been extensively investigated. Usually, they combine the use of low-fibre diet and faecal/fluid tagging. The ingestion of a positive contrast agent (either barium, iodine or a combination of the two),needed to differentiate stool or fluid residues from true colonic lesions, is now considered mandatory. A low-fibre diet has the aim of improving residue homogeneity and facilitates tagging; however, there aren't significative evidences at support. The aim of this study is to compare a new regimen of reduced bowel preparation that does not include low fiber diet with another reduced bowel preparation including low-fiber diet. Primary outcome is the overall quality of bowel preparation.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Different Bowel Preparations in CT Colonography: is Diet Necessary? A Randomized Controlled Trial
Actual Study Start Date :
Oct 1, 2015
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Diet included

Diet is included in bowel preparation

Procedure: Diet
A low-fibre diet for three days before the examination
Other Names:
  • diet included
  • Drug: Faecal Tagging
    Oral ingestion of iodinated contrast media (Gastrografin 60 ml) 3h before the examination
    Other Names:
  • iodinated contrast media (oral)
  • Drug: Bowel cleansing
    Oral ingestion of water solution (macrogol 100 mg, Sanipeg) the day before the examination
    Other Names:
  • chatartic bowel preparation
  • Procedure: CT colonography
    CT Examination of the colon aimed to detect polyps and cancer
    Other Names:
  • Virtual colonoscopy
  • Experimental: Diet not included

    Diet is not included in bowel preparation

    Drug: Faecal Tagging
    Oral ingestion of iodinated contrast media (Gastrografin 60 ml) 3h before the examination
    Other Names:
  • iodinated contrast media (oral)
  • Drug: Bowel cleansing
    Oral ingestion of water solution (macrogol 100 mg, Sanipeg) the day before the examination
    Other Names:
  • chatartic bowel preparation
  • Procedure: CT colonography
    CT Examination of the colon aimed to detect polyps and cancer
    Other Names:
  • Virtual colonoscopy
  • Outcome Measures

    Primary Outcome Measures

    1. overall quality of bowel preparation using a 0-3 scale for each parameter (Homogeneity of solid-fluid fecal tagging, volume of residual fluid, colon distension). [1 day]

      the evaluation of overall quality of bowel preparation on CT colonography images including: homogeneity of tagging, presence of unmarked solid stool residues, the evaluation of volume of residual fluids and colon distention.

    Secondary Outcome Measures

    1. compliance of patients [1 day]

      A 0-10 visual analogical scale (VAS) was used with 0 corresponding to no discomfort and 10 to severe discomfort with severe impact on patient's daily activities. Intermediate values corresponded to intermediate values of tolerance.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Asymptomatic patients (Screening Patients)

    • Symptomatic patients unwilling to undergo optical colonoscopy (Symptomatic Patients)

    • Patients with a previous incomplete optical colonoscopy.

    Exclusion Criteria:
    • Allergy to Macrogol

    • Cognitive behavioral deficits

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 ICOT Hospital, Sapienza Latina Italy 04100

    Sponsors and Collaborators

    • University of Roma La Sapienza

    Investigators

    • Study Director: Laghi Andrea, Professor, University of Rome "Sapienza" Faculty of Medicine and Dentistry Department of Radiological Sciences, Oncology and Pathology I.C.O.T. - Via F. Faggiana 34, 04100 Latina, Italy

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Davide Bellini, Medical Doctor, University of Roma La Sapienza
    ClinicalTrials.gov Identifier:
    NCT02371655
    Other Study ID Numbers:
    • URomLSDBAL1
    First Posted:
    Feb 25, 2015
    Last Update Posted:
    May 12, 2017
    Last Verified:
    May 1, 2017
    Keywords provided by Davide Bellini, Medical Doctor, University of Roma La Sapienza
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 12, 2017